hydrazine has been researched along with Cortical Lewy Body Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melis, RJ; Rikkert, MG; Sjögren, MJ; Spies, PE; Verbeek, MM | 1 |
| Blankenberg, FG; Gilad, R; Lampl, Y; Lorberboym, M; Sadeh, M | 1 |
2 other study(ies) available for hydrazine and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Dementia, Vascular; Female; Humans; Hydrazines; Lewy Body Disease; Male | 2009 |
Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Annexin A5; Dementia; Dementia, Vascular; Female; Humans; Hydrazines; Injections, Intravenous; Lewy Body Disease; Ligands; Magnetic Resonance Imaging; Male; Middle Aged; Nicotinic Acids; Phosphatidylserines; Pilot Projects; Technetium; Tomography, Emission-Computed, Single-Photon | 2006 |